- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Total 570 results
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer; Acrotech Biopharma Inc.RecruitingMetastatic Uveal MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCActive, not recruitingLung Cancer | Non-small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNatera, Inc.; Viewray Inc.Active, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedMalignant GliomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of HealthCompletedColorectal CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteTrod Medical, US,LLCCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedA Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaGlioblastomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); SmithKline BeechamCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute of Nursing Research (NINR)Active, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Roswell Park Cancer InstituteCompletedSmoking CessationUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSusan G. Komen Breast Cancer FoundationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); BioGene Life ScienceCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Pfizer; Oncovir, Inc.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Sanofi; Genentech, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Malignant Tumor of PeritoneumUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); BioGene Life ScienceCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Novartis; Lymphoma Research FoundationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingBreast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Residual Disease | HER2 Positive Breast CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingPancreatic CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research...Completed
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Eli Lilly and CompanyCompletedLung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKyowa Hakko Kirin Pharma, Inc.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingPancreatic CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingUrothelial Carcinoma | Non-Invasive Bladder Urothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Celgene CorporationCompleted
-
Georgetown UniversityWayne State University; H. Lee Moffitt Cancer Center and Research InstituteCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseTerminatedOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Leptomeningeal DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Jazz PharmaceuticalsTerminatedSmall-cell Lung Cancer | Relapsed Small Cell Lung Cancer | Recurrent Small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Invasive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | HER2 Positive Breast Carcinoma | Stage III Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; SmithKline BeechamCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoH. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJohns Hopkins All Children's HospitalWithdrawnNeoplasms, Nerve Tissue | Neuroblastoma
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research ProgramRecruitingSmoking Cessation | Cervical Cancer | High Grade Cervical DysplasiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research ProgramRecruitingLung Diseases | Lung Cancer, Protection AgainstUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research ProgramCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research ProgramCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteEli Lilly and Company; Genentech, Inc.TerminatedNon-Small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEli Lilly and Company; Aventis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research ProgramCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA)Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedLung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; Puma Biotechnology, Inc.RecruitingNeratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal CancerGastric Cancer | GastroEsophageal CancerUnited States